Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.3%

1 terminated/withdrawn out of 43 trials

Success Rate

95.5%

+8.9% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

71%

15 of 21 completed trials have results

Key Signals

11 recruiting15 with results

Enrollment Performance

Analytics

N/A
30(93.8%)
Phase 2
2(6.3%)
32Total
N/A(30)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (43)

Showing 20 of 43 trials
NCT05007925Not ApplicableCompleted

Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

Role: lead

NCT06662500Not ApplicableRecruiting

FORWARD CAD IDE Study

Role: lead

NCT05102019Not ApplicableRecruiting

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Role: lead

NCT05755711Active Not Recruiting

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Role: lead

NCT07057323Not ApplicableEnrolling By Invitation

Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure

Role: collaborator

NCT05966662Not ApplicableCompleted

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Role: lead

NCT05862558Recruiting

Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR

Role: collaborator

NCT06149650Recruiting

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

Role: collaborator

NCT06938854Not ApplicableActive Not Recruiting

Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries

Role: lead

NCT02710435Active Not Recruiting

REDUCER-I: An Observational Study of the Neovasc Reducer™ System

Role: lead

NCT05145478Recruiting

CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

Role: collaborator

NCT04253171Not ApplicableCompleted

Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions

Role: collaborator

NCT07205068Not ApplicableRecruiting

Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure

Role: collaborator

NCT03039855Not ApplicableCompleted

Tiara™ Transcatheter Mitral Valve Replacement Study

Role: lead

NCT07130526Not ApplicableRecruiting

Distrupt Stiffness Trial

Role: collaborator

NCT07062471Not ApplicableNot Yet Recruiting

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)

Role: lead

NCT05858905Not ApplicableCompleted

FORWARD PAD IDE Study With the Shockwave Javelin IVL Catheter

Role: lead

NCT05058456Not ApplicableCompleted

Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

Role: lead

NCT06332911Recruiting

Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair

Role: collaborator

NCT02276547Not ApplicableActive Not Recruiting

Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System

Role: lead